Curcumin enhanced the antiptoliferative activity of 5-fu in colorectal cancer cells
- سال انتشار: 1396
- محل انتشار: سومین سمپوزیوم بین المللی سرطان نسترن
- کد COI اختصاصی: NASTARANCANSER03_082
- زبان مقاله: انگلیسی
- تعداد مشاهده: 410
نویسندگان
Metabolic Syndrome Research Center, Mashhad University Of Medical Sciences, Mashhad, Iran
Metabolic Syndrome Research Center, Mashhad University Of Medical Sciences, Mashhad, Iran- Cancer Research Center, Mashhad University Of Medical Sciences, Mashhad, Iran
Metabolic Syndrome Research Center, Mashhad University Of Medical Sciences, Mashhad, Iran-Department Of Medical Biochemistry, Mashhad University Of Medical Sciences, Mashhad, Iran
چکیده
Colorectal cancer (CRC), is the third leading cause of cancer-related death. Against this background, Wnt/β-catenin pathway is shown to be associated with cell proliferation and cell resistance to chemotherapy. Furthermore, several studies have been shown the therapeutic potential of curcumin in different tumors, including CRC. The aim of current study was to explore the anti-proliferative activityof curcumin in two- and three-dimensional models of CRC cells. The cytotoxic activity of curcumin was investigated in CT26 by MTT assay (3-[4,5-dimethylthiazol-2-yl]2,5-diphenyltetrazolium bromide assay) as well as in three-dimensional models of CRC. The anti-proliferative activity of curcumin alone and in combination with 5-FU was assessed. Also, the expression level of Cyclin D1 was studied beforeand after treatment. Curcumin suppressed cell growth in CT26 cells and the IC-50 value was reduced from ~300 uM to ~32 uM in curcumin+5-FU combination. Moreover, tumor shrinkage was detected after 7 days in curcumin treatment group. Also, the expression level of cyclin D1 was significantly reduced (~22%) in the treatment group versus control group. We demonstrated the antitumor activity of curcumin in CRC cells, supporting further investigations on the role of this anticancer agent with 5- FU in vivo modelکلیدواژه ها
Colorectal Cancer, Cell and Cancer, Nutrition and Cancer, Cancer Treatment and Management, Drugs and Cancerاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.